Top

CAR-T Cell Therapy in Autoimmune Diseases as Concomitant or Main Indication: a 2-step Joint Study on behalf of EBMT ADWP and CTIWP

Autoimmune Diseases Working Party (ADWP)
Study type:
Closed Survey/Study
Study number:
8410046
Type of treatment:
CAR T
Diseases:
Auto immune disorders
Short title:
CAR-T in AD
Primary objective:
Step1: e-Survey on EBMT centre's policy for the management of AD patients treated with CAR-T
Key inclusion criteria:
All EBMT centres performing CAR-T for AD patients or developing programs to start treating AD patients with CAR-T in 2025
Country:
All EBMT member countries
Principal investigator:
Raffaella Greco
EBMT Study coordinator:
Manuela Badoglio
Study coordinator email:
manuela.badoglio@ebmt.org
EBMT Study Unit:
Paris Study Unit
Reason for processing personal data:
Not applicable to surveys
Categories of personal data collected:
Not applicable to surveys
Recipients who may access the data:
Not applicable to surveys
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
Not applicable to surveys

Privacy notices

Article 6 lawful basis for processing personal data:
Not applicable to surveys
Article 9 basis for processing special category data:
Not applicable to surveys

Data Protection Impact Assessments

Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
Not applicable to surveys
Retention Schedule (if possible):
Not applicable to surveys